Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind double-dummy active-controlled multicenter study of Sanqi Tongshuan Tablets in recovery-stage ischemic stroke
CTR20201124Phase 2Active
- Sponsor
- 昆明肾脏病研究所
- Start
- Jun 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Sanqi Tongshuan Tablets in ischemic stroke, sponsored by 昆明肾脏病研究所. Started Jun 2020; status: active.
02
Drugs
Sanqi Tongshuan Tablets
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20201124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201124.